Linda Hemphill

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

Joseph L. Witztum, Daniel Gaudet, Steven D. Freedman et al. · New England Journal of Medicine · 2019 · 669 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

Ravi Thadhani, Tuelay Kisner, Henning Hagmann et al. · Circulation · 2011 · 337 citations · Full text

Medicine, Maternal Health, Obstetrics +15

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.

Howard N. Hodis, Wendy J. Mack, Stanley P. Azen et al. · Circulation · 1994 · 326 citations · Full text

Medicine, Cardiology, Pharmacology +17

Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States

Emil M. deGoma, Zahid Ahmad, Emily C. O’Brien et al. · Circulation Cardiovascular Genetics · 2016 · 226 citations · Full text

Medicine, Cardiology, Preventive Medicine +17

Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Ioanna Gouni‐Berthold, Veronica J. Alexander, Qingqing Yang et al. · The Lancet Diabetes & Endocrinology · 2021 · 226 citations

Medicine, Pharmacology, Pharmacotherapy +2